Fuertes, Samuel B.
HRN: 25-45-65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2025
CEFTRIAXONE 1G (VIAL)
06/14/2025
06/21/2025
IV
2 Grams
Q24
Grangrenous L Foot
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes